HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaobing Jiang Selected Research

Glioblastoma (Glioblastoma Multiforme)

7/2022Natural killer cell awakening: unleash cancer-immunity cycle against glioblastoma.
8/2021MicroRNA-744-5p inhibits glioblastoma malignancy by suppressing replication factor C subunit 2.
6/2021Long non-coding RNA OIP5-AS1 inhibition upregulates microRNA-129-5p to repress resistance to temozolomide in glioblastoma cells via downregulating IGF2BP2.
1/2021RPP25 as a Prognostic-Related Biomarker That Correlates With Tumor Metabolism in Glioblastoma.
1/2021Tumor-treating fields (TTFields)-based cocktail therapy: a novel blueprint for glioblastoma treatment.
8/2019Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists.
1/2018Angiopep-2/IP10-EGFRvIIIscFv modified nanoparticles and CTL synergistically inhibit malignant glioblastoma.
12/2010Inhibitory effects of TNP-470 in combination with BCNU on tumor growth of human glioblastoma xenografts.
1/2004Anti-angiogenesis effect on glioma of attenuated Salmonella typhimurium vaccine strain with flk-1 gene.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaobing Jiang Research Topics

Disease

28Neoplasms (Cancer)
07/2022 - 12/2010
17Osteoporosis
01/2022 - 10/2015
17Glioma (Gliomas)
01/2022 - 01/2004
9Glioblastoma (Glioblastoma Multiforme)
07/2022 - 01/2004
7Compression Fractures (Compression Fracture)
05/2021 - 11/2014
6Pituitary Neoplasms (Pituitary Adenoma)
01/2022 - 12/2013
6Carcinogenesis
01/2021 - 12/2013
4Bone Resorption
01/2022 - 04/2016
4Prolactinoma (Prolactinomas)
11/2021 - 07/2017
3Adenoma (Adenomas)
10/2021 - 11/2018
3Bone Diseases (Bone Disease)
08/2021 - 01/2019
3Intervertebral Disc Displacement (Herniated Disc)
06/2021 - 01/2018
3Brain Neoplasms (Brain Tumor)
01/2018 - 12/2013
2Musculoskeletal Diseases (Musculoskeletal Disease)
01/2022 - 01/2021
2Inflammation (Inflammations)
01/2022 - 01/2022
2COVID-19
03/2021 - 01/2020
2Intracranial Hypertension
02/2021 - 01/2019
2Osteoporotic Fractures
01/2021 - 12/2016
2Melanoma (Melanoma, Malignant)
01/2020 - 11/2008
2Breast Neoplasms (Breast Cancer)
12/2019 - 11/2019
2Fibrosis (Cirrhosis)
01/2019 - 11/2018
1Neuroinflammatory Diseases
08/2022
1Parkinson Disease (Parkinson's Disease)
08/2022
1Hyperprolactinemia
11/2021
1Astrocytoma (Pilocytic Astrocytoma)
09/2021
1Hemifacial Spasm
09/2021
1Cerebral Hemorrhage
08/2021
1Hepatocellular Carcinoma (Hepatoma)
08/2021
1Rupture
06/2021
1Intracranial Aneurysm (Cerebral Aneurysm)
06/2021

Drug/Important Bio-Agent (IBA)

10MicroRNAs (MicroRNA)IBA
06/2021 - 01/2013
9GlucocorticoidsIBA
01/2022 - 10/2015
7Proteins (Proteins, Gene)FDA Link
09/2021 - 01/2017
6Biomarkers (Surrogate Marker)IBA
09/2021 - 01/2019
5Messenger RNA (mRNA)IBA
01/2022 - 01/2017
5Peptides (Polypeptides)IBA
09/2021 - 09/2007
5plastrum testudinisIBA
08/2021 - 08/2016
5Temozolomide (Temodar)FDA LinkGeneric
06/2021 - 08/2019
3Immune Checkpoint InhibitorsIBA
01/2022 - 01/2020
3Estrogens (Estrogen)FDA Link
01/2022 - 03/2015
3Dopamine Agonists (Dopamine Agonist)IBA
11/2021 - 07/2017
3Long Noncoding RNAIBA
06/2021 - 11/2015
3Pharmaceutical PreparationsIBA
03/2021 - 11/2018
3Therapeutic UsesIBA
01/2021 - 04/2017
3EpitopesIBA
10/2010 - 09/2007
2Circular RNAIBA
01/2022 - 01/2019
2VaccinesIBA
12/2021 - 01/2004
2CytokinesIBA
12/2021 - 07/2020
2amsonic acid (DAS)IBA
11/2021 - 07/2017
2Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
09/2021 - 01/2021
2LuciferasesIBA
08/2021 - 01/2019
2EndoglinIBA
08/2021 - 01/2021
2Growth Hormone (Somatotropin)IBA
04/2020 - 01/2019
2Insulin-Like Growth Factor I (IGF-1)IBA
04/2020 - 01/2019
2RNA (Ribonucleic Acid)IBA
02/2020 - 12/2019
2Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
08/2019 - 01/2017
2Bromocriptine (Parlodel)FDA LinkGeneric
11/2018 - 07/2017
2Dexamethasone (Maxidex)FDA LinkGeneric
04/2016 - 10/2015
2HLA-A2 Antigen (HLA A2 Antigen)IBA
10/2010 - 09/2007
2HLA Antigens (Human Leukocyte Antigens)IBA
10/2010 - 09/2007
2Interleukin-13 Receptors (Interleukin 13 Receptor)IBA
12/2007 - 09/2007
1EndocannabinoidsIBA
08/2022
1NF-kappa B (NF-kB)IBA
01/2022
1zuo gui wanIBA
01/2022
1LigandsIBA
01/2022
1PAM2-CSK4IBA
01/2022
1Interleukin-17 (Interleukin 17)IBA
01/2022
1ProlactinIBA
01/2022
1LipopeptidesIBA
01/2022
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2022
1kaempferolIBA
01/2022
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022
1Monoclonal AntibodiesIBA
12/2021
1NitrogenIBA
09/2021
1ChaperoninsIBA
09/2021
1ParaffinIBA
09/2021
1Formaldehyde (Formol)FDA Link
09/2021
1Brain-Derived Neurotrophic Factor (BDNF)IBA
08/2021
1ChemokinesIBA
08/2021
1Interferon-gamma (Interferon, gamma)IBA
08/2021
1Replication Protein C (Replication Factor C)IBA
08/2021
1rhyncophyllineIBA
08/2021
1Single-Chain AntibodiesIBA
08/2021
1Antisense RNA (Anti-Sense RNA)IBA
06/2021

Therapy/Procedure

12Therapeutics
01/2022 - 01/2015
10Immunotherapy
07/2022 - 09/2007
5Vertebroplasty
05/2021 - 11/2014
4Radiotherapy
01/2021 - 08/2019
3Chinese Traditional Medicine (Traditional Chinese Medicine)
08/2021 - 01/2019
3Drug Therapy (Chemotherapy)
01/2021 - 01/2019
2Diskectomy (Discectomy)
06/2021 - 01/2020
2Decompression
06/2021 - 04/2018
2Operative Time
02/2021 - 09/2016
2Adjuvant Radiotherapy
01/2021 - 10/2019
2Ovariectomy (Oophorectomy)
01/2020 - 04/2016
2Kyphoplasty
11/2017 - 09/2016
1Transcranial Magnetic Stimulation
08/2022
1Reoperation
10/2021
1Microvascular Decompression Surgery
09/2021
1Endoscopes
06/2021